Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03661723 |
|---|---|
| Brief Title: | Pembrolizumab and Reirradiation in Bevacizumab Naïve and Bevacizumab Resistant Recurrent Glioblastoma |
| First Submitted : | September 5, 2018 |
| First Submitted that Met QC Criteria : | September 6, 2018 |
| First Posted : | September 7, 2018 |
| Results First Submitted : | December 26, 2022 |
| Results First Posted with QC Comments : | April 6, 2023 |
| Results First Submitted that Met QC Criteria : | April 6, 2023 |
| Results First Posted : | April 7, 2023 |
| Last Update Submitted that Met QC Criteria : | April 22, 2024 |
| Last Update Posted : | April 26, 2024 |